Moxetumomab Pasudotox-tdfk and Sucralfate Oral Suspension
Determining the interaction of Moxetumomab Pasudotox-tdfk and Sucralfate Oral Suspension and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: sucralfate
Brand name: Carafate
Synonyms: Sucralfate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab Pasudotox-tdfk-Sucralfate Suspension
- Moxetumomab Pasudotox-tdfk-Sucralfate Tablet
- Moxetumomab Pasudotox-tdfk-Sucralfate Tablets
- Moxetumomab Pasudotox-tdfk-Sucrets 4-Hour Cough Drops
- Moxetumomab Pasudotox-tdfk-Sucroferric oxyhydroxide
- Moxetumomab Pasudotox-tdfk-Sudafed
- Sucralfate Oral Suspension-Moxetumomab pasudotox-tdfk Intravenous
- Sucralfate Oral Suspension-Moxifloxacin
- Sucralfate Oral Suspension-Moxifloxacin (Systemic)
- Sucralfate Oral Suspension-Moxifloxacin Hydrochloride
- Sucralfate Oral Suspension-Moxifloxacin Injection
- Sucralfate Oral Suspension-Moxifloxacin Intravenous